Evidence map›Paper›PMID 41142332›Full record

ArticleACS central science2025

Reshaping of a Glycoside Hydrolase Active Site through Expression-Compensated Droplet-Based Microfluidic Screening Provides Useful Tools for Glycomics.

Jacob F Wardman, Feng Liu, Saulius Vainauskas, Charlotte Olagnon, Teresa A Howard, Yuqing Tian, Seyed A Nasseri, Rajneesh K Bains, Christopher H Taron, Stephen G Withers

Abstract read
In one paragraph

Article in ACS central science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jacob F WardmanDepartment of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.ORCID https://orcid.org/0000-0002-8235-3576
Feng LiuMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Saulius VainauskasNew England Biolabs, Ipswich, Massachusetts 01938, United States.
Charlotte OlagnonMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.ORCID https://orcid.org/0000-0002-1485-5865
Teresa A HowardMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Yuqing TianMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Seyed A NasseriMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.ORCID https://orcid.org/0000-0002-8380-7701
Rajneesh K BainsMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Christopher H TaronNew England Biolabs, Ipswich, Massachusetts 01938, United States.
Stephen G WithersDepartment of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.ORCID https://orcid.org/0000-0002-6722-5701

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glycosylation of proteins endows them with distinct biophysical properties and allows them to play fundamental roles in cellular communication. Much of our understanding of glycoproteins has derived from the ability to enzymatically manipulate glycan structures. In particular, selective cleavage of glycans from proteins simplifies the analysis of glycoproteins and the determination of structure-activity relationships. However, limited enzymatic tools are available for the study of mucin-type O-glycans. To address this, we carried out the directed evolution of a glycoside hydrolase to increase its ability to cleave the sialyl T-antigen, a ubiquitous O-glycan structure in humans. We employed ultrahigh-throughput droplet-based microfluidics to rapidly screen vast libraries of variants in pL-sized droplets, thus minimizing the quantities of complex substrate required. Furthermore, by use of fluorescent protein-fusion and ratiometric gating during droplet sorting we could account for varying expression levels and identify highly active hits that could have been overlooked due to lower expression levels. Within just two rounds of screening, we uncovered variants with 840-fold enhancements in activity and new specificities compared to those of the WT enzyme. This campaign highlights the versatility of glycoside hydrolases and provides a broadly applicable strategy to engineer enzymatic tools for glycomics through microfluidic screening.

Identifiers

PMID41142332
PMCPMC12550630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.